Skip to main content
. 2021 Aug 10;187:106569. doi: 10.1016/j.rmed.2021.106569

Table.

Comparing Sputnik V with top COVID-19 vaccines (from [56], modified).

Sputnik V AZD1222 or Vaxzevria Ad26.COV2·S or Janssen COVID-19 Vaccine BNT162b2 or tozinameran or Comirnaty mRNA-1273 or Moderna COVID-19 vaccine or Spikevax
Type of vaccine Adenovirus vector (Ad26 priming and Ad5 boost) Adenovirus vector (nonreplicating chimpanzee adenovirus) Adenovirus vector (Ad26) mRNA in lipid nanoparticles mRNA (part of virus genetic code) in lipid nanoparticles
Efficacy 91.6% 62–90% 66.3% 95% 94.5%
Storage requirement −18.5 °C (liquid form)
2–8 °C (dry form)
2–8 °C 2–8 °C −70 °C ± 10 °C −20 °C ± 5 °C
Number of shots X2 (3 weeks apart) X2 (8–12 weeks apart) X1 X2 (3 weeks apart) X2 (4 weeks apart)
Cost per dose $10 $2.15 in the EU; $3–4 in the UK and U.S.; $5.25 in South Africa $10 $19.50 $25-$37
Efficacy on variants Unknown. Clinical trials were largely conducted in Russia prior to the emergence of major variants. Some data suggest reduced effect against the Beta and Gamma variants Little effect against the Beta variant, but appears effective against Alpha and Gamma variants Effective against the variants, although less so against Beta and Gamma variants Lab data suggest “quite effective” against Alpha variant as well as Beta and Gamma variants Lab data suggest “quite effective” against Alpha variant as well as Beta and Gamma variants